Literature DB >> 12502512

Impact of two common polymorphisms in the PPARgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: thrifty genotype, thrifty phenotype, or both?

Pernille Poulsen1, Gitte Andersen, Mogens Fenger, Torben Hansen, Søren M Echwald, Aage Vølund, Henning Beck-Nielsen, Oluf Pedersen, Allan Vaag.   

Abstract

The Pro12Ala polymorphism in the PPARgamma2 gene has been associated with reduced risk of type 2 diabetes and insulin resistance. Recently, an association between dizygotic twinning and PPARgamma gene polymorphisms has been proposed. We investigated the phenotypic appearance of the two polymorphisms (Pro12Ala and exon 6 C-->T) in PPARgamma among elderly twins (207 monozygotic [MZ] and 342 dizygotic [DZ]) and evaluated whether they could explain previously reported differences in plasma glucose and insulin profiles among MZ and DZ twins. We demonstrated a significant impact of the Pro12Ala polymorphism on glucose tolerance, diabetic status, homeostasis model assessment for insulin resistance, and plasma insulin profiles in twins. No impact of the silent exon 6 polymorphism on glucose homeostasis or plasma insulin profiles was found. Independent of the polymorphisms, we observed a significant impact of zygosity status per se on the plasma insulin profile after oral glucose ingestion, with the MZ twins being more hyperinsulinemic, indicating insulin resistance, than the DZ twins. Nonsignificantly higher glucose concentrations were observed among MZ compared with DZ twins. We demonstrated an association between the Ala allele and reduced risk of diabetes and insulin resistance in twins. However, the differences in metabolic profiles among MZ and DZ twins were not explained by differences in frequencies of the genetic variants and may be due to intrauterine environmental factors operating in twins independent of genotype. Accordingly, our study simultaneously supports a role for both the intrauterine environment (thrifty phenotype) and for genetics (thrifty genotype) in the etiology of insulin resistance and perhaps glucose intolerance in twins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502512     DOI: 10.2337/diabetes.52.1.194

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

1.  Effect of the peroxisome proliferator-activated receptor-gamma C161T polymorphism on lipid profile in Brazilian patients with Type 2 diabetes mellitus.

Authors:  V Tavares; R D C Hirata; A C Rodrigues; O Monte; J E N Salles; N Scallissi; A C Speranza; S Gomes; M H Hirata
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

2.  Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus.

Authors:  Y M Cho; M D Ritchie; J H Moore; J Y Park; K-U Lee; H D Shin; H K Lee; K S Park
Journal:  Diabetologia       Date:  2004-01-17       Impact factor: 10.122

Review 3.  PPAR gamma and human metabolic disease.

Authors:  Robert K Semple; V Krishna K Chatterjee; Stephen O'Rahilly
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

4.  Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and Asians.

Authors:  Jinlan Ma; Yan Li; Fang Zhou; Xiaoyi Xu; Gang Guo; Yi Qu
Journal:  Mol Vis       Date:  2012-09-10       Impact factor: 2.367

Review 5.  Prevention of nephropathy in patients with type 2 diabetes mellitus.

Authors:  Antonios H Tzamaloukas; Glen H Murata
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.266

6.  Genetic Polymorphisms in the HTR2C and Peroxisome Proliferator-Activated Receptors Are Not Associated with Metabolic Syndrome in Patients with Schizophrenia Taking Clozapine.

Authors:  Shi Hyun Kang; Jong Il Lee; An Kee Chang; Yeon Ho Joo; Chang Yoon Kim; Seong Yoon Kim
Journal:  Psychiatry Investig       Date:  2011-05-26       Impact factor: 2.505

7.  Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.

Authors:  Salvatore De Cosmo; Nicola Motterlini; Sabrina Prudente; Fabio Pellegrini; Roberto Trevisan; Antonio Bossi; Giuseppe Remuzzi; Vincenzo Trischitta; Piero Ruggenenti
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

8.  Tagging single nucleotide polymorphisms in the PPAR-γ and RXR-α gene and type 2 diabetes risk: a case-control study of a Chinese Han population.

Authors:  Juan Du; Hui Shi; Ying Lu; Wencong Du; Yuanyuan Cao; Qian Li; Jianhua Ma; Xinhua Ye; Jinluo Cheng; Xiaofang Yu; Yanqin Gao; Ling Zhou
Journal:  J Biomed Res       Date:  2011-01

9.  PPARγ2 polymorphism and human health.

Authors:  Weimin He
Journal:  PPAR Res       Date:  2009-04-16       Impact factor: 4.964

10.  The Rate of Decline of Glomerular Filtration Rate May Not Be Associated with Polymorphism of the PPARγ2 Gene in Patients with Type 1 Diabetes and Nephropathy.

Authors:  Bingmei Yang; Hongxin Zhao; Beverley Ann Millward; Andrew Glen Demaine
Journal:  PPAR Res       Date:  2014-01-22       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.